Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - roland+martin
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Myelin Basic Protein-specific T cell Clones TL3A6, TL5F6, and TL5G7
Autoreactive T cell clones such as TL3A6 and TL5F6 that recognize an autoantigen, which is potentially relevant for an autoimmune disease, for example, multiple sclerosis (MS), offer the potential to examine the disease pathogenesis and develop new treatments. Such treatments aim at disrupting or interfering with the specific interaction between autoreactive...
Published: 4/8/2024
|
Inventor(s):
Roland Martin
,
Henry McFarland
Keywords(s):
ac5AXX
,
AC5XXX
,
ACXXXX
,
AXXXXX
,
BASIC
,
Cell
,
CLONES
,
Listed LPM Maddox as of 4/15/2015
,
MYELIN
,
Post LPM Assignment Set 20150420
,
Pre LPM working set 20150418
,
PROTEIN-SPECIFIC
,
T
,
TL3A6
,
TL5G7.
Category(s):
Collaboration Sought > Licensing
Methods for the Selection of Subjects for Multiple Sclerosis Therapy
Multiple Sclerosis (MS) is a life-long chronic autoimmune disease diagnosed primarily in young adults who have a virtually normal life expectancy. Estimates place the annual costs of MS in the United States in excess of $2.5 billion. There are approximately 250,000 to 400,000 persons in the United States with MS, and approximately 2.5 million persons...
Published: 4/8/2024
|
Inventor(s):
Roland Martin
Keywords(s):
IA3XXX
,
IAXXXX
,
IXXXXX
Category(s):
Collaboration Sought > Licensing
,
Application > Research Materials
,
TherapeuticArea > Immunology
,
Application > Diagnostics
,
Application > Therapeutics
Method for the Treatment of Multiple Sclerosis
The invention relates to the discovery that humanized antibodies to the interleukin-2 receptor (IL-2R) such as (daclizumab) are effective in treating multiple sclerosis (MS). In particular, it has been discovered that patients who have failed to respond to therapy with interferon-beta show dramatic improvement when treated with daclizumab, with patients...
Published: 10/28/2024
|
Inventor(s):
Roland Martin
Keywords(s):
IB3XXX
,
IBXXXX
,
IXXXXX
Category(s):
Collaboration Sought > Licensing
,
Application > Therapeutics
,
TherapeuticArea > Immunology
,
Application > Diagnostics
,
Application > Research Materials